Alexion is to buy rare diseases biotech Syntimmune and its experimental drug for a rare kind of anaemia, in a deal worth up $1.2 billion. The companies have signed a deal where Alexion will pay $ ...

The Center for American Progress is an independent nonpartisan policy institute that is dedicated to improving the lives of all Americans through bold, progressive ideas, as well as strong ...

On August 30, 2024, Alexion Pharmaceuticals, Inc. and Alexion Pharma International Operations Ltd. (collectively, “Alexion”) and Samsung Bioepis Co. Ltd. (“Samsung Bioepis”) settled their ...

It is expected to cause more than 39 million more fatalities by 2050 — three per minute. That’s according to a large study led by the Global Research on Antimicrobial Resistance (GRAM ...

It is expected to cause more than 39 million more fatalities by 2050 — three per minute. That’s according to a large study led by the Global Research on Antimicrobial Resistance (GRAM ...

Superbugs that are increasingly resistant to infections could kill up to 40 million people between now and 2050, according to new research published in the journal The Lancet. During that time ...

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life ...

The number of male cancer cases around the world is projected to spike from 10.3 million in 2022 to 19 million in 2050 — an ...

A solid option for retirement savers. Our research team assigns Bronze ratings to strategies they’re confident will outperform a relevant index, or most peers, over a market cycle on a risk ...

Airlines are committed to reducing their carbon footprint and achieving net-zero emissions by 2050. In the meantime, there are things airlines can do – and in many cases are already doing ...

A straightforward glide path delivers vintages in five-year increments from 2065 through 2010. Starting with 97% equity exposure, that weighting drops 20 percentage points over the first 25 years.

Cancer cases and deaths among men are expected to surge globally by 2050, according to a new study. In the study, published ...